Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Mitacs | INDUSTRY |
| Natural Sciences and Engineering Research Council, Canada | OTHER |
Not provided
Not provided
Not provided
Female endurance athletes are susceptible to iron deficiency and this can impact their exercise performance. This study aims to assess the efficacy of a novel iron supplement in improving iron status, gut microbiome, and exercise performance in endurance-trained females.
Current iron supplements on the market are commonly associated with side effects including gastrointestinal distress, nausea, vomiting, and constipation. As a solution, we have developed a novel delivery system for iron supplementation that overcomes many of these limitations. The goal of this study is to assess the efficacy of a yeast-iron complex in improving iron status, gut microbiome, and exercise performance in young, endurance-trained females with sub-optimal iron status. Participants will consume 40mg of elemental iron every second day for 8 weeks. Before and after supplementation,participants will be assessed for exercise capacity (VO2max), iron status, and the current state of the gut microbiome. each week during supplementation, participants will complete a survey in in which they will report feelings of stress and recovery as well as gastrointestinal symptoms.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Iron/yeast complex (FeSC) | Experimental | Iron Supplement |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| FeSC | Other | Iron/yeast complex |
|
| Measure | Description | Time Frame |
|---|---|---|
| Iron Status | Ferritin | 4 weeks, 8 weeks |
| Hemoglobin | Hemoglobin concentration | 4 weeks, 8 weeks |
| Upper Gut Microbiome | SIMBA capsule | 4 weeks, 8 weeks |
| Lower Gut microbiome | Fecal sample | 4 weeks, 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Exercise Capacity | Oxygen Consumption (VO2max) | 8 weeks |
| Hemoglobin Mass | Carbon monoxide Rebreathing Technique | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Gastrointestinal Symptoms 2 | Patient-Reported Outcomes Measurement Information System | Weekly for 8 weeks |
| Sleepiness | Epworth Sleepiness scale |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jane Shearer, PhD | University of Calgary | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Calgary | Calgary | Alberta | T2N4N1 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000090463 | Iron Deficiencies |
| ID | Term |
|---|---|
| D019189 | Iron Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Gastrointestinal Symptoms 1 | Gastrointestinal Symptoms Questionnaire | Weekly for 8 weeks |
| Weekly for 8 weeks |
| Stress and Recovery | The Recovery-Stress Questionnaire | Weekly for 8 weeks |